If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Keep me logged in Forgot your password?

Please wait...

Please wait...

Bladder Cancer More Likely with Radiotherapy

May 20, 2012

Radiation therapy for prostate cancer (PCa) is associated with a greater likelihood of bladder cancer development compared with radical prostatectomy (RP), Japanese researchers reported at the American Urological Association 2012 annual meeting.
 

Study: Immediate Intravesical Chemotherapy Underused

May 20, 2012

Immediate intravesical chemotherapy (IVC) is underused in bladder cancer patients, according to a presentation at the American Urological Association 2012 annual meeting.
 

Presenting Symptoms May Aid in Initial Bladder Cancer Diagnosis

May 19, 2012

Irritative urinary symptoms are encountered more frequeny among patients with bladder cancer who are exposed to bladder carcinogens as a result of occupational activities, according to a Brazilian study presented at the American Urological Association 2012 annual meeting.
 

Spread of Bladder Cancer To Lungs Tied to a Protein

April 30, 2012

Versican—a protein involved in cancer cell migration—is a driver of lung metastasis in bladder cancer.
 

Adding Chemo to Radiotherapy for MIBC Improves Outcomes

April 25, 2012

Synchronous chemotherapy combined with radiotherapy significantly improves locoregional control of muscle-invasive bladder cancer (MIBC) compared with radiotherapy alone, according to British researchers.
 

Bladder Cancer Diagnosis Encourages Smokers to Quit

April 23, 2012

Most commonly cited reasons for quitting: bladder cancer diagnosis, advice of urologist
 

Neoadjuvant Chemotherapy Urged for Rare Type of Bladder Cancer

April 20, 2012

Neoadjuvant chemotherapy for patients with small cell urothelial carcinoma (SCUC) improves their likelihood of survival compared with a historical cohort of patients treated with initial cystectomy, a study found.
 

Prolonged Hospital Stays After Cystectomy Decreasing

March 30, 2012

The likelihood of a prolonged hospital stay following radical cystectomy in the United States has decreased in the past decade, a study found.
 

Female Gender, Low BMI Raise Bladder Perforation Risk

March 23, 2012

Female gender and low body mass index (BMI) are risk factors for inadvertent bladder performation during transurethral resection of bladder tumors, German researchers reported online ahead of print in the Journal of Urology.
 

Bladder Cancer Death Risk May No Longer Be Higher in Women

February 27, 2012

PARIS—Previous research has shown that cancer-specific survival (CSS) after radical cystectomy for bladder cancer is significantly worse for women than men, but new data presented at the 27th Annual Congress of the European Association of Urology suggest that this may no longer be the case.
 

Prophylactic Antibiotics Unnecessary for Outpatient Cystoscopy

February 25, 2012

PARIS—Antibiotic prophylaxis and risk-based stratification are unnecessary for most patients undergoing outpatient flexible cystoscopy, researchers reported at the 27th Annual Congress of the European Association of Urology.
 

Study: Form of Bladder Cancer Increased by 56%

February 22, 2012

Although a detailed trend analysis of 127,614 U.S. cases of first primary bladder cancer demonstrated a 9% overall drop in disease occurrence between 1973 and 2007, papillary transitional cell carcinoma (PTCC)—one of two main subtypes—increased by 56% over that period.
 

Active Surveillance An Option for Bladder Cancer

February 16, 2012

LONDON—Low-risk non-muscle invasive bladder cancer (NMIBC) could be safely managed by periods of active surveillance rather than aggressive resection surgery and frequent cystoscopic follow up.
 

Circulating Tumor Cells Predict Worse Outcomes in Bladder Cancer Patients

February 04, 2012

SAN FRANCISCO—The presence of circulating tumor cells (CTC) in the peripheral blood of patients with urothelial carcinoma of the bladder (UCB) prior to radical cystecomy are associated with worse disease outcomes, researchers reported here at the annual Genitourinary Cancers Symposium.
 

Similar Outcomes Found with Open, Robotic Cystectomy

February 04, 2012

SAN FRANCISCO—Researchers who compared open and robotic cystectomy for bladder cancer found no significant difference in key outcomes after a median three years of follow-up, according to study findings presented here at the annual Genitourinary Cancers Symposium.
 

Comorbid Illnesses Worsen Post-Cystectomy Outcomes

February 01, 2012

Greater comorbid illness increases the likelihood of complications after radical cystectomy for bladder cancer among patients older than 70 years, according to German researchers.
 

Smaller Bladder Tumors Less Like to Recur After Surgery

December 10, 2011

Non-muscle-invasive bladder tumors 15 mm or less in diameter are associated with a lower risk of recurrence after surgical treatment compared with larger tumors, according to researchers.
 

Extended LND Improves Outcomes in Selected Bladder Cancer Patients

November 28, 2011

Extended lymph node dissection (LND) does not significantly change overall disease recurrence and survival patterns in patients who undergo radical cystectomy for bladder cancer compared with limited LND, but certain patient subgroups experience improvements in these outcomes, a study found.
 

Diabetes Increases Bladder Ca Recurrence, Progression Risk

November 21, 2011

Diabetes mellitus (DM) appears to be an independent predictor of disease recurrence and progression among patients with non-muscle invasive bladder cancer (NMIBC), according to investigators.
 

Neutrophil/Lymphocyte Ratio Can Upstage Bladder Cancer Patients Prior to Surgery

November 04, 2011

SAN FRANCISCO—Prior to radical cystectomy for bladder cancer, preoperative neutrophil/lymphocyte ratio (NLR) can identify patients at risk for having non-organ-confined disease and who may benefit from neoadjuvant chemotherapy, University of Wisconsin investigators reported at the American College of Surgeons 97th Clinical Congress.
 

Cancer Risk Higher in Transplant Recipients

November 02, 2011

Infection-related and unrelated cancers develop more frequently in solid organ transplant recipients than in the general population, according to researchers.
 

Bladder Cancer Survival Lowest in Blacks

November 01, 2011

Among patients with the malignancy, blacks are 29% more likely to die than whites, a study found.
 

Cystoscopy Alone is the Most Cost-Effective Way to Detect Bladder Cancer Recurrence

October 26, 2011

Cystoscopy without the aid of urinary markers is the most cost-effective strategy for detecting recurrence of non-invasive bladder cancer, according to researchers.
 

Bladder Cancer Recurrence More Likely in Smokers

September 20, 2011

Smokers and ex-smokers who undergo transurethral resection of non-muscle-invasive bladder cancer (NMIBC) are at higher risk for disease recurrence compared with nonsmokers, according to new data.
 

Insufficient Evidence for Routine Bladder Cancer Screening

September 07, 2011

In an update to its 2004 guidance on screening for bladder cancer, the United States Preventive Services Task Force (USPSTF) has changed its recommendation from a D (lack of evidence) to an I (insufficient evidence) statement, finding inadequate data to support disease screening for asymptomatic adults or for adults with mild lower urinary tract symptoms such as urinary frequency, hesitancy, urgency, dysuria, or nocturia.
 

Data Back LNU for Upper Tract Urothelial-Cell Carcinoma

August 22, 2011

Laparoscopic and open nephroureterectomy for upper urinary tract urothelial-cell carcinoma (UUT-UCC), which are uncommon but aggressive malignancies, are associated with comparable long-term outcomes, Scottish investigators concluded.
 

Physicians Seldom Follow Bladder Cancer Guidelines

August 05, 2011

Physicians seldom following clinical guidelines for managing patients with high-grade, non-muscle-invasive bladder cancer, according to an online report in Cancer.
 

Pre-Cystectomy Smoking Linked to Worse Outcomes After Surgery

May 17, 2011

WASHINGTON, D.C.—Pre-cystectomy smoking habits influence survival following radical cystectomy for bladder cancer, according to researchers.
 

Lymph Node Density May Help Predict Bladder Cancer Death Risk

May 15, 2011

WASHINGTON, D.C.—Lymph node density (LN-density) may have prognostic relevance in patients with lymph node-positive bladder cancer (LNposBCA), according to a new German study presented at the American Urological Association 2011 annual meeting.
 

Robot-Assisted Radical Cystectomy Safe, Feasible for Octogenarians

May 15, 2011

WASHINGTON, D.C.—Robot-assisted radical cystectomy (RARC) is safe and feasible in octogenarians, researchers reported here at the American Urological Association 2011 annual meeting.
 

Mortality from Renal and Pelvis Cancers Higher in Places with Fewer Docs

May 14, 2011

WASHINGTON, D.C.—Mortality rates from kidney and renal pelvis cancers (KCa) are increased significantly in places with a low population density of physicians, according to a study presented at the American Urological Association 2011 annual meeting.
 

Induction BCG Sufficient for High-Risk NMIBC

May 05, 2011

Bacillus Calmette-Guérin (BCG) treatment without maintenance in patients with high-risk non-muscle-invasive bladder cancer (NMIBC) compares favorably with trials in which comparable patients received maintenance BCG.
 

Cigarette Smoking More Strongly Linked to Invasive Bladder Cancer

April 18, 2011

Cigarette smoking is more strongly associated with an increased risk of invasive bladder cancer than with low-grade superficial bladder cancer, according to California researchers.
 

Drug May Be an Alternative to Cystectomy for BCG Failures

March 21, 2011

VIENNA—Mycobacterial cell wall DNA complex (MCC) may provide an alternative to cystectomy for patients with non-muscle invasive bladder cancer refractory to bacillus Calmette-Guérin (BCG) treatment, according to preliminary study findings.
 

Gene Test Predicts Bladder Cancer Spread

March 14, 2011

A gene test helped predict the risk of node-positive disease in patients with bladder disease so that beneficial neoadjuvant chemotherapy could be administered before cystectomy, researchers reported in Lancet Oncology (2011;12:137-143).
 

Blood Test Predicts Bladder Cancer Risk

March 14, 2011

A blood test can accurately detect biomolecular markers of bladder cancer resulting from environmental carcinogens, according to a study.
 

Patient's Widow Sues Urologist for Failure to Diagnose Bladder Tumor

January 11, 2011

Dr. P, 52, was not an alarmist. In fact, he was known to be a urologist with a particularly calm and relaxing manner who did not order unnecessary tests or procedures. His patients were generally happy with this. Some of them even sought him out because of his calm demeanor and his attitude of watchful waiting rather than burdening his patients with dire possibilities and numerous tests.
 

British Researchers Explore New Technique for Bladder Cancer Treatment

November 22, 2010

British researchers say it may be time to replace cystectomy with chemo-radiotherapy as the primary treatment for muscle invasive bladder cancer. John Schieszer spoke with the researchers and has the story in today's Medical Minute.
 

Testing Begins for Novel Urinary Diversion Approach

November 16, 2010

Tengion, Inc., a company developing ways create autologous new organs and tissues, has announced that it has implanted its Neo-Urinary Conduit in the first patient as part of a phase 1 clinical trial.
 

Selenium May Protect Against Bladder Cancer

November 02, 2010

High selenium intake may have a protective effect against bladder cancer, mainly among women, according to a recent meta-analysis.
 

Age Affects Bladder Cancer Treatment Outcomes

September 24, 2010

Octogenarians with non-muscle-invasive bladder cancer (NMIBC) have the worst outcomes after bladder-preserving treatment, data show.
 

Bladder Cancer Risk Higher in Painters, Study Shows

September 24, 2010

A meta-analysis of 41 studies involving more than 2,900 bladder cancer cases or deaths among painters revealed that such workers were 28% more likely than members of the general population to develop bladder cancer—even after adjusting for cigarette smoking, the most important risk factor for the disease.
 

More Bladder Cancer Is Metastatic at Diagnosis

July 28, 2010

BARCELONA—Researchers have documented a small but significant stage migration in metastatic bladder cancer between 1988 and 2006.
 

Imaging Agent for Bladder Cancer Okayed

July 27, 2010

The FDA has approved Cysview (hexaminolevulinate HCl), an optical imaging agent indicated for use in the cystoscopic detection of non-muscle-invasive papillary bladder cancer in patients suspected or known to have lesions on the basis of prior cystoscopy.
 

Dye Workers Face Long-Term Bladder Cancer Risk

July 14, 2010

Even 30 or more years after their last exposure to aromatic amines, which are known bladder carcinogens, individuals have an excess risk of bladder cancer, a study found.
 

Novel Agent May Work for Advanced Urothelial Cancer

July 12, 2010

CHICAGO—A novel drug called eribulin may be effective for advanced urothelial cancer (UC), even in patients with prior adjuvant or neoadjuvant chemotherapy, according to new data presented at the American Society of Clinical Oncology annual meeting.
 

Red Meat Lovers May Have Higher Bladder Cancer Risk

May 24, 2010

A 12-year study of 1,762 individuals found that the risk of bladder cancer is about 1.5 times higher among people who eat the most red meat compared with those who eat the least, especially when the food is cooked at high temperatures or eaten well done.
 

Drug Improved Metastatic Bladder Cancer Survival

May 21, 2010

In a recent study, zoledronic acid decreased the incidence of skeletal-related events (SREs) and improved one-year survival in patients with bone metastases from bladder cancer, according to a study.
 

Radical Cystectomy's Role in Bladder Cancer Treatment

April 01, 2010

VIENNA—Radical cystectomy should be considered in all cases of muscle-invasive, non-metastatic bladder cancer, according to Marek Babjuk, MD, PhD, who presented an evidence-based argument for this approach at the 7th Meeting of the European Association of Urology Section of Oncological Urology.
 

Office-Based Bladder Cancer Procedures Rise

April 01, 2010

The trend followed changes in CMS policy that boosted reimbursement.
 

Postop Epirubicin Improves Bladder Cancer Outcomes

April 01, 2010

Intravesical instillations of epirubicin after transurethral resection (TUR) for non-muscle-invasive bladder tumors may be effective as prophylaxis against recurrence, according to investigators.
 

Gemcitabine May Hold Promise for BCG Failures in Bladder Cancer Patients

February 25, 2010

Gemcitabine might be a second-line treatment option for patients with high-risk non-muscle-invasive bladder cancer (BC) who fail therapy with bacille Calmette-Guérin (BCG), according to Italian researchers.
 

BCG Superior For Treating Bladder Cancer

February 16, 2010

BCG cut the risk of cancer-related death risk by 53% versus epirubicin.
 

Lymphovascular Invasion Predicts Worse Outcomes

February 16, 2010

It is associated with a higher risk of recurrence and death from upper tract urothelial carcinoma.
 

Lead Exposure, Bladder Cancer May Be Linked

January 27, 2010

Lead exposure may be associated with the initiation and development of bladder cancer, according to a study conducted in Poland.
 

Arsenic Exposure Possibly Protective Against Bladder Cancer

November 24, 2009

High levels of arsenic reduced mortality by 50% compared with low levels.
 

Prostate-Sparing Cystectomy Is Safe

November 23, 2009

This approach has oncologic outcomes similar to that of standard cystoprostatectomy, study shows.
 

Genetic Data Confirm Bladder Cancer Link to Smoking

November 19, 2009

Researchers who analyzed genetic data from patients with bladder cancer discovered three common inherited genetic variants, also known as polymorphisms, which are significantly associated with development of this malignancy.
 

Radiation Is a Viable Option for Invasive Bladder Cancer

November 19, 2009

Two-year survival is similar to that achieved with cystectomy.
 

Bladder Tumor Substaging May Improve Outcome Predictions

October 23, 2009

TORONTO—Substaging of bladder cancer tumors provides important prognostic information that could help guide patient management decisions, according to researchers.
 

Valrubicin Is Reintroduced for the Treatment of CIS

October 16, 2009

Endo Pharmaceuticals, of Chadds Ford, Pa., has reintroduced Valstar (valrubicin) for the treatment of carcinoma in situ (CIS) of the urinary bladder that is refractory to treatment with Bacillus-Calmette-Guérin (BCG).
 

An Alternative to Radical Cystectomy

September 18, 2009

Bladder-sparing protocol involving brachytherapy and EBRT shows promise in bladder cancer patients.
 

Urologic Cancers Rise in Denmark

September 17, 2009

The overall incidences of kidney, bladder, pelvis, and ureter cancers in Denmark increased in both sexes from 1944 to 2003, Danish investigators reported in Urology (2009; published online ahead of print).
 

Bladder Cancer Survival Linked to COX-2

August 19, 2009

TORONTO—Patients with muscle-invasive bladder cancer whose tumors express cyclooxygenase-2 (COX-2) appear to have improved disease-specific survival.
 

Dietary Beta-Carotene Lowers Urothelial Carcinoma Risk

July 16, 2009

Dietary beta-carotene is associated with a reduced risk of urothelial carcinoma (UC), especially among current smokers, according to a large Danish study.
 

HAL Does Not Improve Bladder Cancer Survival

June 18, 2009

Hexaminolevulinate-enhanced fluorescence (HAL) cystoscopy significantly increased the rate of recurrence-free survival in patients with muscle-invasive bladder cancer in a German study.
 

Surgery Delay Poses Risk

June 18, 2009

Bladder cancer patients who undergo partial cystectomy (PC) more than 12 weeks after transurethral resection of bladder tumors are at three times higher risk of requiring salvage radical cystectomy than those who have a shorter interval between the procedures, a study found.
 

Phase 3 Trial of Bladder Cancer Drug Completes Recruitment

May 05, 2009

Under the FDA's Accelerated Approval program, Bioniche Life Sciences, Inc., has completed phase 3 recruitment registration for its agent Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory to BCG.
 

Cystectomy Follow-Up May Be Avoidable

May 04, 2009

Follow-up examinations offer no survival benefit to patients who are asymptomatic following radical cystectomy for bladder cancer, according to a study published in The Journal of Urology (2009;181:1587-1593).
 

Delayed Diagnosis Raises Bladder Cancer Death Risk

April 27, 2009

CHICAGO—Delays in the diagnosis of bladder cancer confer an approximately 30% increased risk of death from the malignancy, researchers found.
 

Effects of Smoke on Bladder Cancer Treatment

April 07, 2009

Last year, our lab team received a grant from the Flight Attendants Medical Research Institute (FAMRI). FAMRI was created from a settlement with tobacco companies over flight attendant exposure to secondhand smoke in their work.
 

Diagnosing, Treating Refractory OAB

, April 02, 2009

Idiopathic overactive bladder (OAB) is a common condition in the United States, with a prevalence of 16% for men and 16.9% for women (World J Urol. 2003;20:327-336). OAB is costly, with related expenditures for 2000 estimated
 

Current Smokers Diagnosed with Bladder Cancer Earlier

March 17, 2009

Bladder cancer is diagnosed about six years earlier in current smokers than in current nonsmokers, according to Japanese investigators.
 

Bladder Ca Therapy and the Elderly

November 25, 2008

SAN FRANCISCO—Conventional treatments for bladder cancer may be inappropriate in elderly patients because of underlying age-related functional impairment and comorbidities, according to a medical oncologist.
 

Intravesical BCG Should Be Used First for Prophylaxis

November 01, 2008

Intravesical instillation of bacillus Calmette-Guérin (BCG) is most effective in the long term when selected as initial prophylactic treatment to prevent recurrence of superficial bladder cancer, according to a Japanese study.
 

Urine Test Detects Bladder Cancer

November 01, 2008

Counting copies of a specific gene in cells gathered from a urine sample may provide a simple, noninvasive way to detect bladder cancer, according to researchers at The University of Texas MD Anderson Cancer Center in Houston.
 

Cultured Milk May Cut Bladder Cancer Risk

October 30, 2008

Consuming cultured milk products may decrease the risk of bladder cancer, according to Swedish researchers.
 

NBI Detects More Bladder Ca Recurrences

October 01, 2008

Narrow-band imaging (NBI) cystoscopy improves detection of recurrent non-muscle-invasive bladder tumors over standard white-light imaging (WLI) cystoscopy, according to a report in BJU International (2008; published online ahead of print).
 

Urine Test Detects Upper Tract TCC

September 01, 2008

With upper tract transitional cell carcinoma (UTTCC), vigilance is the watchword. Detecting this cancer earlier may directly impact patient survival. According to the American Cancer Society, 54,390 new cases and 14,100 deaths in the United States will occur during 2008.
 

UroVysion Not a Replacement for Cystoscopy, Study Finds

September 01, 2008

The UroVysion (UV) assay, which can diagnose urothelial cancer, cannot replace cystoscopy for monitoring patients with non-muscle-invasive bladder cancer. According to researchers in Sweden, the assay may be useful as a supplement to traditional measures for detecting carcinoma in situ (CIS).
 

Water Intake May Diminish Likelihood of Bladder Cancer

September 01, 2008

Water intake may be associated with a slightly reduced risk of bladder cancer, especially in women, a study suggests.
 

Autoantibodies For Bladder Ca Diagnosis

July 21, 2008

SAN DIEGO—Serum autoantibody profiling may provide a novel non-invasive diagnostic tool for bladder cancer, according to researchers at the Spanish National Cancer Research Center in Madrid.
 

EBRT for Prostate Cancer Hikes Risk of Secondary Cancers

May 23, 2008

ORLANDO, Fla.—External beam radiation therapy (EBRT) increases the risk of secondary malignancies relative to radical prostatectomy in men with localized prostate cancer, data show.
 

Acrylamide May Hike Renal Cell Cancer Risk

May 08, 2008

Dietary intake of acrylamide, a probable human carcinogen, may be associated with an increased risk of renal cell cancer, according to a report in the American Journal of Clinical Nutrition (2008;87:1428-1438).
 

Intravesical Gemcitabine For Superficial Bladder Cancer

May 06, 2008

SAN FRANCISCO—Intravesical gemcitabine may be a safe and effective treatment for superficial bladder cancer, data suggest.
 

Statins Reduce Bladder Cancer Progression Risk

May 06, 2008

SAN FRANCISCO—Statin use may decrease the likelihood that superficial bladder cancer will progress to muscle-invasive disease requiring cystectomy, according to researchers at the University Hospital of Montreal in Canada.
 

Bladder Cancer Worse in Renal Transplant, ESRD Patients

May 05, 2008

SAN FRANCISCO—Renal transplant recipients and non-transplant patients with end-stage renal disease (ESRD) who develop bladder cancer have more extensive disease distribution at diagnosis than bladder cancer patients in the general population.
 

Bladder CIS Extent Predicts Post-BCG Disease Progression

May 01, 2008

Treatment with bacillus Calmette-Guérin (BCG) is effective for carcinoma in situ (CIS) of the bladder, according to Japanese researchers.
 

Technique Clears Obstructed Ureters

May 01, 2008

WASHINGTON D.C.—The placement of transileal retrograde nephrostomy catheters (rPCN) is a safe and effective treatment for post-surgical ureteral obstruction following non-continent urinary diversion procedures, according to new data presented here at the 33rd Annual Scientific Meeting of the Society of Interventional Radiology (SIR).
 

High CRP Worsens Prognosis

March 14, 2008

Elevated C-reactive protein (CRP) levels before chemoradiotherapy for muscle-invasive bladder cancer is associated with a poor prognosis, according to researchers at Tokyo Medical and Dental University in Japan.
 

TCC in Transplant Patients

February 27, 2008

Transitional cell carcinoma (TCC) is the predominant malignancy to develop in Chinese renal transplant recipients, according to researchers at the Capital University of Medical Sciences in Beijing.
 

Manufacturing Issue Delays Restart of CIS Drug

February 26, 2008

Indevus Pharmaceuticals, Inc., of Lexington, Mass., has received a non-approvable letter from the FDA for Valstar (valrubicin solution), the only approved product for therapy of bacillus Calmette-Guérin-refractory carcinoma in situ of the urinary bladder.
 

Robotic Cystectomies Have Advantages

November 01, 2007

Robotic radical cystectomy (RC) may offer advantages over open surgery without compromising pathologic measures of early oncologic efficacy, researchers suggest.
 

One Third of Standard BCG Dose May Be Sufficient

November 01, 2007

One third of the standard dose of bacillus Calmette-Guérin (BCG) could be recommended as adjuvant treatment for intermediate-risk superficial bladder tumors, Spanish researchers say.
 

Man Wins $1.6 Million in Missed Bladder Cancer Case

November 01, 2007

A terminally ill Illinois man has won a $1.6 million verdict against the general practitioner who failed to diagnose bladder cancer.
 

Gemcitabine Prevents TCC Relapse

September 01, 2007

CHICAGO—Intravesical gemcitabine is an effective and well tolerated adjuvant local chemotherapy in patients with superficial bladder cancer, according to researchers in Algeria.
 

Bladder Cancer Sex Differences

September 01, 2007

Twice as many men as women are treated for bladder cancer, according to a study.
 

Chemotherapy Plus Radiotherapy May Enable Bladder Preservation

August 06, 2007

Combining cisplatin-based intra-arterial chemotherapy and radiotherapy is effective long-term for local invasive bladder carcinoma, according to a Japanese study.
 

Bladder Cancer Risk Higher in TURP-Treated BPH Patients

July 01, 2007

A study of Swedish men with BPH found no excess risk of bladder cancer, but did show that the likelihood of the malignancy is elevated in those who undergo transurethral resection of the prostate (TURP), especially men with comorbid genitourinary tract conditions.
 

Cystoscopy Superior to Urine Test

June 01, 2007

The sensitivity of the UroVysion DNA urinary test is too low to be considered an alternative to cystoscopy in the follow-up of patients with superficial bladder cancer, according to researchers in Sweden.
 
Popular Topics
Acute Kidney Injury AKI Androgen Deprivation Anemia Benign Prostatic Hyperplasia Bladder Cancer BPH Cardiovascular Disease Chronic Kidney Disease Circumcision CKD CVD Dialysis End-stage Renal Disease Hemodialysis Overactive Bladder Prostate Cancer Renal Cell Carcinoma Reproductive Medicine Secondary Hyperparathyroidism Transplantation Urinary Incontinence Urinary Tract Infection Urology UTI

 

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions